Annalisa Jenkins
CIK 1639481 · President and CEO · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$381.6K
Companies
8
Total Filings
36
Lifetime Open-Market Net
-$42.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYE | Director | — | $0.61 | — | $0 | 4 | 2026-04-02 |
| MREO | Director | — | $0.31 | — | $0 | 3 | 2026-02-27 |
| CMPS | Director | 19,480 | $10.85 | $211.4K | -$42.2K | 11 | 2025-06-13 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | — | $16.80 | — | $0 | 5 | 2023-06-08 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 2 | 2021-06-23 |
| ARDX | Director | 33,471 | $5.08 | $170.2K | $0 | 5 | 2019-06-17 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | President and CEO | — | — | — | $0 | 4 | 2017-11-07 |
| ONCOSEC MEDICAL Inc (ONCS) Delisted | Director | — | $0.28 | — | $0 | 1 | 2017-09-05 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-31 | CMPS | Sell (S) | −3,384 | -$42.2K | EDGAR |
| 2021-06-23 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-17 | ARDX | Grant (A) | +20,072 | $0 | EDGAR |
| 2019-06-13 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-13 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-15 | ARDX | Grant (A) | +13,399 | $0 | EDGAR |
| 2017-11-07 | Dimension Therapeutics, Inc. (DMTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2017-09-05 | ONCOSEC MEDICAL Inc (ONCS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.